Latest Headlines

  1. Sysmex Inostics' OncoBEAM™ Demonstrates Clinical Validity And Superior Performance Versus Pan-Cancer NGS For Blood-Based Mutation Detection For Hepatocellular Carcinoma

    Data recently published in Clinical Cancer Research demonstrate the advantages of using an ultra-high sensitivity test for detection of mutations which may predict therapeutic efficacy for hepatocellular carcinoma (HCC)

  2. Diagnostic Solutions Laboratory Revolutionizes Precision Medicine With GenomicInsight™ Genomic Health Profile Powered By Opus23 Explorer™

    Diagnostic Solutions Laboratory (DSL) continues its innovative vision to transform and improve personalized medicine by introducing its first DNA SNP test, GenomicInsight™ Genomic Health Profile powered by Opus23 Explorer™, a proprietary version of DataPunk's Opus23 informatics software, conceived, developed, and coded by Dr. Peter D'Adamo, Distinguished Professor of Clinical Sciences, University of Bridgepor

  3. Porvair Launch US Manufactured Sample Storage Microplate

    Porvair Sciences announces that its industry standard 96-well sample storage plate - the round bottom 1ml deep well microplate is now available manufactured in the USA

  4. MolecularMD Is Acquired By ICON

    MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that it has been acquired by ICON plc (NASDAQ: ICLR)

  5. American Premium Water Corp. (HIPH) Announces The Creation Of Laboratory Facility In Southern California Focusing On Nano-Technology To Support CBD And THC Efforts

    American Premium Water Corporation (OTC: HIPH) announces that it has established its own laboratory which will focus on the testing the Company’s proprietary hydro-nano technology

  6. New Pneumatic Presston™ 1000 Positive Pressure Manifold Increases Productivity For 96-Well Plate Processing

    Phenomenex, Inc., a global leader in the research, design, and manufacture of advanced technologies for the separation sciences, introduces Presston™ 1000 Positive Pressure Manifold for 96-well plate sample preparation processing

  7. Intertek Debuts Building And Construction Laboratory In Minnesota With State-Of-The Art Facilities And Services To Support The Industry

    Intertek, a leading Total Quality Assurance provider to industries worldwide, is pleased to announce the unveiling of its new building and construction laboratory in Minnesota, offering state-of-the-art services in a 70,000 square-foot facility

  8. Minomic Signs Agreement With US Pathology Laboratory

    Minomic International Ltd is pleased to announce the company has executed an agreement with Cirrus Dx, a CLIA Certified “High Complexity” Laboratory, enabling US clinicians and patients early access to the company’s novel test for Prostate Cancer

  9. Bio-Rad Releases First FDA-Cleared Digital PCR System And Test For Monitoring Chronic Myeloid Leukemia Treatment Response

    Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, recently announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance

  10. Fujirebio Diagnostics Receives FDA Breakthrough Device Designation For Lumipulse G Β-Amyloid Ratio (1-42/1-40) Quantitative In Vitro Diagnostic Test

    Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received Breakthrough Device Designation (formerly known as Expedited Access Pathway (EAP) designation) from the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on February 1, 2019 for the Lumipulse G β-Amyloid Ratio (1-42/1-40) quantitative in vitro diagnostic test